title: Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone.
abstract: Polymorphonuclear leukocytes (PMNLs) from uremic patients have elevated basal levels of cytosolic calcium ([Ca2+]i), reduced calcium signal after activation of Fc(gamma) RIII receptor, and impaired phagocytosis. Chronic excess of parathyroid hormone (PTH) in uremia mediates its effect on PMNL's metabolism and function through the sustained elevation of their [Ca2+]i. Because calcium channel blockers interfere with this effect of PTH on PMNLs, treatment of patients on hemodialysis with verapamil, nifedipine, or amlodipine was associated with an improvement in metabolism and phagocytosis of PMNLs in humans. The therapy with calcium channel blockers should be continued in order to maintain its beneficial effects.
authors.affiliation: Division of Nephrology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
authors.forename: S
authors.initials: S
authors.lastname: Massry
authors.forename: M
authors.initials: M
authors.lastname: Smogorzewski
mesh_terms: D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D020013:Calcium Signaling / Q000187:drug effects; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000503:physiopathology; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D007239:Infections / Q000209:etiology; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D010281:Parathyroid Hormone / Q000502:physiology*; D010587:Phagocytosis / Q000187:drug effects; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications / Q000503:physiopathology* / Q000628:therapy
chemical_list: D002121:Calcium Channel Blockers; D010281:Parathyroid Hormone